Clinical Trial Update: Comparing Risk and Severity of IRRs in Patients Premedicated With Cetirizine vs. Diphenhydramine Prior to Ocrelizumab [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing pretreatment with cetirizine versus diphenhydramine to assess risk and severity of infusion reactions in patients receiving ocrelizuma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Cetirizine (cetirizine)
• Diphenhydramine (diphenhydramine)
• Ocrelizumab (ocrelizumab)

Snippet

Sponsor: Providence Health & Services | Conditions: Multiple Sclerosis, Infusion Reaction | Phase 3 | Status: COMPLETED | Results posted: 2024-03-04